Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2004-07-29
2009-10-20
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S358000
Reexamination Certificate
active
07605161
ABSTRACT:
Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula (I): wherein: W is —O—, —N(R1)—, C(O), S(O)t; (where t is 0, 1 or 2), N(R1)S(O)2, S(O)2N(R1), C(O)N(R1) or N(R1)C(O)N(R1); and V is C(O), C(S), C(O)N(R1)—, C(O)O—, S(O)2—, S(O)2N(R1)— or C(R11)H; and x, y, R1, R2, R3, R4, R5, R6, R7, R7a, R8, R8a, R9, R9a, R10 and R10aare defined herein. Pharmaceutical compositions comprising the compounds of formula (I) are also disclosed.
REFERENCES:
patent: 2006/0252767 (2006-11-01), Sviridov et al.
patent: 2006/0293308 (2006-12-01), Abreo et al.
patent: 0385350 (1990-09-01), None
patent: 1180514 (2002-02-01), None
patent: 1243268 (2002-09-01), None
patent: 1396487 (2004-03-01), None
patent: 2004-203871 (2004-07-01), None
patent: WO-88/07527 (1988-10-01), None
patent: WO-88/08424 (1988-11-01), None
patent: WO-01/62954 (2001-08-01), None
patent: WO-01/68619 (2001-09-01), None
patent: WO-01/96327 (2001-12-01), None
patent: WO-02/088093 (2002-11-01), None
patent: WO-02/102778 (2002-12-01), None
patent: WO-03/045921 (2003-06-01), None
patent: WO-03/066604 (2003-08-01), None
patent: WO-03/075929 (2003-09-01), None
patent: WO-03/091247 (2003-11-01), None
patent: WO-2004/035549 (2004-04-01), None
patent: WO-02/081453 (2004-10-01), None
Hirayama et al. Diabetes Care, 2007, 30(5), 1289-91.
Internatioal Search Report, PCTUS2004/024657, Feb. 15, 2005.
Jacobsen, Jon E. et al. “2-Aminomethyl) chromans that inhibit iron-dependent lipid peroxidation and protect against central nervous system trauma and ishemia”; Journal of Medicinal Chemistry, vol. 35, No. 23, 1992, pp. 4464-4472.
Jacobsen E. J. et al. “Novel 21 Aminosteroids that inhibit iron-dependent lipid peroxidation and protect against central nervous system trauma”; Journal of Medicinal Chemistry, vol. 33, No. 4, 1990, pp. 1145-1151.
Chemical Abstracts Service, Columbus, Ohio, US; DN: 87:201475, 1977, Thunus: “Synthesis and pharmacological” p. 1-3.
Office Action dated Jun. 16, 2008, issued by the Canadian Intellectual Property Office in related Canadian Application No. 2,533,900 (6 pages).
Abreo Melwyn
Bagherzadeh Mehran Seid
Gschwend Heinz W.
Harvey Daniel F.
Hudson Cindy J.
Jarrell Noble
Osha • Liang LLP
Wilson James O
Xenon Pharmaceuticals Inc.
LandOfFree
Pyridyl derivatives and their use as therapeutic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridyl derivatives and their use as therapeutic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridyl derivatives and their use as therapeutic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4078820